Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Halberd Corp HALB

Halberd Corporation is a holding company. The Company is engaged in the acquisition vehicle for established businesses. It is also developing treatments for neurodegenerative diseases, such as post-traumatic stress disorder/chronic traumatic encephalopathy (PTSD/ CTE), Alzheimer’s disease and Parkinson’s disease. It has two issued patents and four provisional patent applications related to the... see more

Recent & Breaking News (OTCPK:HALB)

Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study

GlobeNewswire October 1, 2024

Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD

GlobeNewswire September 11, 2024

Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg(TM) for Veteran Suicide Reduction

GlobeNewswire September 9, 2024

Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg(TM) for Veteran Suicide Reduction

GlobeNewswire September 4, 2024

Halberd Corp. Issues Letter to Shareholders

GlobeNewswire August 26, 2024

Halberd Corp's (OTC: HALB) Groundbreaking Traumatic Brain Injury (TBI) Mitigation Nasal Spray Shows Promising Phase II Initial Test Results

GlobeNewswire July 24, 2024

Halberd/Athena GTX Research Promises a Much Brighter Future

Accesswire May 22, 2024

Halberd's Traumatic Brain Injury Treatment Projects Align with New U.S. House Bill

Accesswire May 9, 2024

Halberd's Patented LDN+ Drug Has Begun Pre-Pilot Trials With Military Veterans

Accesswire April 30, 2024

Halberd's Patented Drug, LDN+, the Subject of a Limited Clinical Trial Under an Innovative Four-Company Cooperative Research and Development (CRADA) Contract

Accesswire April 4, 2024

Halberd and Mississippi State University to Commence Stage II Advanced TBI Nasal Spray Testing

Accesswire February 8, 2024

Halberd's Top Executives Join Forces with Athena GTX CEO Mark Darrah Unveiling 2024 Powerful Partnership Outlook on "The Street Reports Podcast"

Accesswire February 6, 2024

Halberd Corporation 2023 Year-End CEO Update and 2024 Goals

Accesswire January 11, 2024

CORRECTION BY SOURCE: Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX

Accesswire January 10, 2024

Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX

Accesswire January 9, 2024

Halberd Corporation Signs Multi-Faceted Agreement with CrodenHealth.com

Accesswire December 13, 2023

Halberd Corporation Plans to Extend Research Partnership with Mississippi State University

Accesswire November 15, 2023

Hartman, CEO, and Dr. Felder, CTO of Halberd Corp, Featured on The Street Reports Podcast

Accesswire October 10, 2023

Halberd's Traumatic Brain Injury (TBI) Testing Results Replicated at Mississippi State University (MSU)

Accesswire October 4, 2023

Halberd and Athena GTX Collaborate on Advanced Traumatic Brain Injury (TBI) Monitoring and Applications for Government Contracts

Accesswire September 20, 2023